Elleder M, Bradová V, Smíd F, Budĕsínský M, Harzer K, Kustermann-Kuhn B, Ledvinová J, Král V, Dorazilová V
1st Institute of Pathology, School of Medicine, Czechoslovak Academy of Sciences, Prague.
Virchows Arch A Pathol Anat Histopathol. 1990;417(5):449-55. doi: 10.1007/BF01606034.
Fabry's disease was diagnosed in an adult patient as a lipid storage-induced non-obstructive hypertrophic cardiomyopathy. Stable angina pectoris started 15 years before death, was followed by slowly progressive heart failure and repeated pulmonary thromboembolism with death at 63 years. Autopsy disclosed enormous cardiomegaly (1100 g), cardiac storage of ceramide trihexoside (CTH) of the same intensity as in classical cases of generalized Fabry's disease (11 mg lipid/g wet weight) restricted to cardiocytes. Other tissues (liver, kidney, brain, pancreas, pulmonary artery, coronary arteries) were free of storage. Using proton magnetic resonance analysis on formaldehyde-fixed tissue the stored CTH was identified as globotriaosylceramide. It was enzymatically degradable by control cell cultures but left uncleaved by mutant reference Fabry cells. Alpha-galactosidase activities in peripheral leucocytes of all four of the patient's daughters were in the heterozygous range. The diagnostic difficulties in this monosymptomatic novel variant of Fabry's disease are stressed.
法布里病在一名成年患者中被诊断为脂质贮积性非梗阻性肥厚型心肌病。稳定型心绞痛在患者死亡前15年开始出现,随后是缓慢进展的心力衰竭和反复的肺血栓栓塞,患者63岁时死亡。尸检发现心脏巨大(1100克),心肌细胞中神经酰胺三己糖苷(CTH)的贮积程度与经典的全身性法布里病病例相同(11毫克脂质/克湿重),其他组织(肝脏、肾脏、大脑、胰腺、肺动脉、冠状动脉)无贮积。通过对甲醛固定组织进行质子磁共振分析,确定贮积的CTH为球三糖基神经酰胺。它可被对照细胞培养物酶解,但突变的法布里病参考细胞无法将其裂解。患者四个女儿外周血白细胞中的α-半乳糖苷酶活性均处于杂合范围。强调了这种法布里病单症状新变体的诊断困难。